AXIM BIOTECHNOLOGIES, INC. (AXIM) Operating margin 2015–2023
AXIM BIOTECHNOLOGIES, INC. (AXIM) operating margin by fiscal year — reported operating income divided by reported revenue.
-6961.0%FY2023 · since FY2015: -20451.3% → -6961.0%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2023 | -6961.0% | +45464.6 pp |
| FY2022 | -52425.6% | -29311.1 pp |
| FY2021 | -23114.5% | — |
| FY2019 | -388.9% | +2185.7 pp |
| FY2018 | -2574.5% | +4045.0 pp |
| FY2017 | -6619.5% | +1369.3 pp |
| FY2016 | -7988.8% | +12462.4 pp |
| FY2015 | -20451.3% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice